Addictive Disorders – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Addictive Disorders – Drugs In Development, 2024 report and make more profitable business decisions.
Addictive disorders, such as substance abuse and dependence, are common disorders that involve the overuse of alcohol and/or drugs. Addiction develops over time and is a chronic and relapsing illness. Addictive disorders are caused by multiple factors, including genetic vulnerability, environmental stressors, social pressures, individual personality characteristics and psychiatric problems.
The Addictive Disorders drugs in development market research report provide comprehensive information on the therapeutics under development for Addictive Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Addictive Disorders and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Addictive Disorders | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 18 molecules, with 16 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Addictive Disorders therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Addictive Disorders pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Addictive Disorders treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Adial Pharmaceuticals IncAlgernon Pharmaceuticals Inc
AWAKN Life Sciences Corp
Biomind Labs Inc
Delix Therapeutics Inc
Eolas Therapeutics Inc
Innovation1 Biotech Inc
Kinnov Therapeutics
Mydecine Innovations Group Inc
Neurai Life Sciences
PNB Vesper Life Science Pvt Ltd
Psilera Inc
PSYLO Pty Ltd
Sanford Burnham Prebys Medical Discovery Institute
Statera Biopharma Inc
U.S. National Institutes of Health
Vivozon Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Pharmaceuticals reports